Skip to main content

Table 1 Molecular characteristics of clinical fluconazole non-susceptible Candida spp. blood isolates

From: Molecular mechanisms of azole resistance in Candida bloodstream isolates

Isolate reference

MIC, ug/mL

Gene expression (fold increase)

Erg11p amino acid substitution(s)

FLC

VRC

POS

ERG11

CDR1

CDR2

MDR1

 

C. albicans

CW138

4 (SDD)

0.12 (S)

0.25 (NWT)

0.41

1.60

9.01

0.18

A114S, Y257H

CW357

4 (SDD)

0.25 (SDD)

0.25 (NWT)

0.18

1.08

5.79

0.15

A114S, Y257H

CW241

128 (R)

4 (R)

1 (NWT)

0.58

4.49

122.50

141.28

A114S, Y257H

CW216

128 (R)

≥8 (R)

≥8 (NWT)

0.15

0.79

3.32

4.86

E266D, V488I

C. glabrata

CW193

64 (R)

4 (NWT)

≥8 (NWT)

0.46

23.12

23.24

N.A.

None

CW262

64 (R)

0.25 (WT)

0.5 (WT)

1.08

22.45

7.13

N.A.

I166S

CW378

64 (R)

4 (NWT)

2 (WT)

0.56

4.02

8.08

N.A.

None

CW088

≥256 (R)

4 (NWT)

≥8 (NWT)

1.10

19.78

14.55

N.A.

None

CW404

≥256 (R)

≥8 (NWT)

≥8 (NWT)

0.29

18.70

6.92

N.A.

I166S

C. tropicalis

CW190

4 (SDD)

0.25 (SDD)

0.5 (NWT)

0.39

6.11

N.A.

0.47

None

CW219

4 (SDD)

0.5 (R)

0.5 (NWT)

0.95

1.56

N.A.

0.77

None

CW361

4 (SDD)

0.5 (R)

0.25 (NWT)

2.38

0.27

N.A.

0.01

None

CW395

4 (SDD)

0.5 (R)

0.5 (NWT)

0.45

0.63

N.A.

3.27

None

CW071

8 (R)

0.25 (SDD)

0.5 (NWT)

0.11

1.28

N.A.

30.53

None

CW018

16 (R)

0.25 (SDD)

0.25 (NWT)

0.61

2.75

N.A.

23.42

Y132F, S154F

CW107

16 (R)

1 (R)

0.5 (NWT)

0.36

0.09

N.A.

7.12

Y132F, S154F

CW178

16 (R)

0.5 (R)

1 (NWT)

2.83

3.81

N.A.

0.64

None

CW385

16 (R)

0.5 (R)

1 (NWT)

0.12

4.43

N.A.

2.93

None

CW263

64 (R)

4 (R)

0.12 (NWT)

4.45

1.95

N.A.

1.44

Y132F, S154F

CW386

128 (R)

2 (R)

4 (NWT)

1.36

0.68

N.A.

1.33

None

CW065

≥256 (R)

4 (R)

0.5 (NWT)

1.04

1.30

N.A.

23.07

Y132F, S154F

CW067

≥256 (R)

≥8 (R)

1 (NWT)

0.11

0.93

N.A.

7.04

Y132F, S154F, F145 L

CW192

≥256 (R)

≥8 (R)

1 (NWT)

1.36

0.76

N.A.

0.52

Y132F, S154F

CW242

≥256 (R)

≥8 (R)

1 (NWT)

0.50

6.10

N.A.

1.21

Y132F, S154F

CW266

≥256 (R)

4 (R)

0.25 (NWT)

0.27

10.08

N.A.

1.59

None

CW271

≥256 (R)

≥8 (R)

1 (NWT)

7.47

1.30

N.A.

0.31

Y132F, S154F

  1. FLC Fluconazole, VRC Voriconazole, POS Posaconazole, S Susceptible, SDD Susceptible dose-dependent, R Resistant, WT Wild-type, NWT Non wild-type, values in bold represent gene overexpression; underlined values represent heterozygous substitutions